Summary

According to early performance results from a single-arm trial, the Micra Transcatheter Pacing System was safe and effective in patients who required ventricular pacing for a variety of conditions. The serious adverse event rate was 5.7%, but there were no device-related deaths, infections, dislodgements, or reoperation.